A Phase I Study of SHR-4712 in Patients With Advanced Solid Tumors

NCT06993116 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: SHR-4712 Injection

Sponsor

Guangdong Hengrui Pharmaceutical Co., Ltd